Trump Administration Takes Initial Steps To Lower Drug Prices.

“Wonkblog” reports that the Trump Administration “is taking its first concrete steps to address the high cost of prescription medications, narrowly focusing on a measure it could take to increase the competition for old, off-patent drugs.” Food and Drug Administration Commissioner Scott Gottlieb said the agency was creating a “drug competition action plan” to incentivize new generic drugs. According to the Wonkblog, “the effort would likely have a limited impact, affecting prices of older drugs whose patents and exclusivity have expired and lack competitors.” https://www.washingtonpost.com/news/wonk/wp/2017/06/21/trump-administration-signals-initial-steps-to-deal-with-drug-prices/?utm_term=.72fb3c90846b